Patent Expiry
Patent/Exclusivity Expiry: COMETRIQ
- Drug
- COMETRIQ
Other upcoming events for RCUS
Phase 2 StartPhase 2 Start: PRE-surgical NEOadjuvant Sandwich Immunotherapy With HIF inhibiTion in Renal Cell Carcinoma (PRENEOS
Patent ExpiryPatent/Exclusivity Expiry: ONMEL
Phase 3 ReadoutPhase 3 Topline: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chem
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib
Patent ExpiryPatent/Exclusivity Expiry: STIVARGA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.